Speaker illustration

Doctor Madhu Chintala

Spring House (United States of America)

Differential impact of milvexian, an investigational oral FXIa inhibitor vs apixaban and dabigatran on thrombin generation in human donor plasma in vitro

Event: ESC Congress 2022

Topic: Thrombosis, Bleeding

Session: Clinical and basic science insights in vascular disease

Thumbnail

JNJ-9375, a novel exosite 1 thrombin inhibitor does not increase bleeding in a spontaneous gastrointestinal (GI) bleeding model in mice with a mutation of the Adenomatous polyposis coli (Apc) gene

Event: ESC Congress 2018

Topic: Thrombosis, Bleeding

Session: Platelets, haemostasis and coagulation

Thumbnail